In Brief: FDA guidances
This article was originally published in The Tan Sheet
Executive Summary
FDA guidances: Public meeting to discuss issues relating to agency's development and use of guidance documents will take place on April 26 at the National Institutes of Health, Masur Auditorium, Bethesda, Md. At the meeting, issues raised by a citizen petition submitted by the Indiana Medical Devices Manufacturers Council will be explored. FDA published a Federal Register notice on March 7 elucidating its ideas for improving guidance document procedures ("The Tan Sheet" March 11, p. 15); this notice also will be discussed at the meeting, which begins at 9 a.m...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning